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Definition  
Rheumatoid arthritis (RA) is the most common long-
lasting autoimmune inflammatory disorder that 
primarily affects joints typically involved on both sides 
of the body with erosions of the cartilage and bone 
sometimes causes joint deformity, but can also affect 
other organs with significant negative impact on the 
ability to perform daily activities, including work and 
household tasks, and health related quality of life, and 
it increases mortality. 
 
rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf cdc.gov/arthritis/basics/rheumatoid.htm 
US MLE TEST 
A 35-year-old female presents to her family physician with a 
complaint of painful joints for the past 2 weeks. She reports 
symmetric bilateral joint pain in her hands, knees, and ankles. 
Additionally, the patient states that she experienced a cold-
like illness 3 weeks ago that has since resolved. Physical 
examination is significant for a rash on her hands and feet 
that is shown in Figure A. Radiographs of the bilateral hands 
do not show any notable abnormalities. Which of the 
following is the most likely diagnosis as the cause of this 
patient's joint pains?  
1.  Rheumatoid arthritis, 2.  Osteoarthritis, 3.  Parvovirus B19,  
4.  Coxsackievirus, 5.  Reactive arthritis.  
https://www.mommd.com/usmle1to10.shtml 
US MLE TEST EXPLANATION 
The correct answer is 3.  This patient's presentation of symmetric 
arthritis of the hands, knees, and ankles in the context of a preceding 
cold-like illness and papular, purpuric rash in a stocking-glove 
distribution is consistent with a parvovirus B19 infection.  
Incorrect Answers: 
1: Although rheumatoid arthritis can often be clinically indistinguishable 
from parvovirus B19 infection, the history of prior cold-like illness and 
concurrent acral rash make parvovirus B19 infection the more likely, 2: 
The acuity and widespread distribution of the pain is atypical for 
osteoarthritis, 4: Coxsackievirus causes hand, foot, and mouth disease; 
however, it is not associated with development of arthritis, 5: Reactive 
arthritis (Reiter's syndrome) is a reactive arthritis to bacterial infection 
that commonly manifests with a triad of arthritis, conjunctivitis, and 
urethritis. 
https://www.mommd.com/usmle1to10.shtml 
Epidemiology 1  
http://emedicine.medscape.com/article/331715-overview#a5 https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Epidemiology 
• Worldwide, the annual incidence of RA is 
approximately 3 cases per 10,000 population, and 
the prevalence rate is approximately 1%, increasing 
with age and peaking between the ages of 35 and 
50 years.   
• RA is uncommon under the age of 15 and from then 
on the incidence rises with age until the age of 80.   
Epidemiology 2  
http://emedicine.medscape.com/article/331715-overview#a5 https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Epidemiology 
• Women are affected three to five times as often as 
men, but sex differences diminish in older age 
groups.  
• There may be a link between fetal microchimerism 
(in which fetal cells are present in the maternal 
circulation) and RA. 
Epidemiology   
(Rates from RA by country) 
http://buyprovailencheap.org/wp-content/uploads/2013/10/Rheumatoid-arthritis-country.jpg 
Epidemiology   
(Prevalence of RA by Age, Sex, and Region) 
http://www.scielosp.org/img/revistas/bwho/v81n9/a07fig02.gif 
A regions – developed countries everywhere, AF – sub-
Sahar Africa, AM BD - developing countries in the 
Americas, EM – countries in the Eastern Mediterranean 
and North African regions, EU BC – developing countries 
in Europe, SEA – countries in South-east Asia, WP B – 
countries in the Western Pacific region.  
Risk Factors and Etiology 1 
• Age and sex: the incidence of RA is to three times 
higher in women than men.   
• Genetics: specific HLA class II genotypes are 
associated with increased risk of developing RA.  
• Modifiable: reproductive hormonal exposures, 
tobacco use, dietary factors, and microbial 
exposures.  
• Oral contraceptives (OC). 
• Hormone Replacement therapy (HRT).    
http://www.cdc.gov/arthritis/basics/rheumatoid.htm 
Risk Factors and Etiology 2 
• Live Birth History: women who have never had a 
live birth have a slight to moderately increased risk 
of RA. 
• Breastfeeding (RA is less common among women 
who breastfeed). 
• A truncated menstrual history.    
• Early Life Exposures (e.g., maternal smoking 
doubled the risk of children developing RA as 
adults).   
• Decreased physical Activity. 
http://www.cdc.gov/arthritis/basics/rheumatoid.htm 
Risk Factors and Etiology 
(Accent on Genetic Factors) 1 
• Genetic factors account for 50% of the risk for 
developing RA. 
• About 60% of RA patients carry a shared epitope of 
the human leukocyte antigen (HLA)-DR4 cluster, 
which constitutes one of the peptide-binding sites 
of certain HLA-DR molecules associated with RA 
also carries this shared epitope and confers risk.   
http://emedicine.medscape.com/article/331715-overview#a4 
Risk Factors and Etiology 
(Accent on Genetic Factors) 2 
• Genes other than those of the major 
histocompatibility complex (MHC) are also involved, 
and results from sequencing genes of families with 
RA suggest the presence of several resistance and 
susceptibility genes, including PTPN22 and TRAF5. 
• More significant prevalent RA in women than in 
men suggests that genomic imprinting from parents 
participates in its expression.  
http://emedicine.medscape.com/article/331715-overview#a4 
Risk Factors and Etiology 
(Accent on Genetic Factors) 3 
• Epigenetics is the change in DNA expression that is 
due to environmentally induced methylation and 
not to a change in DNA structure.   
http://emedicine.medscape.com/article/331715-overview#a4 
Risk Factors and Etiology 
(Accent on Infectious Agents) 
Infectious agents as potential causes of RA:  
• Mycoplasma organisms,  
• Epstein-Barr virus (EBV),  
• Rubella virus.  
• This suggestion is indirectly supported by the 
following evidence: 
• Periodontopathic bacteria, including 
Porphyromonas gingivalis. 
http://emedicine.medscape.com/article/331715-overview#a4 
Risk Factors and Etiology 
(Accent on Hormonal Factors) 
• Sex hormones may play a role in RA, as evidenced 
by the disproportionate number of females with 
this disease, its amelioration during pregnancy, its 
recurrence in the early postpartum period, and its 
reduced incidence in women using oral 
contraceptives. 
• Hyperprolactinemia may be a risk factor for RA. 
http://emedicine.medscape.com/article/331715-overview#a4 
Risk Factors and Etiology 
(Accent on Immunologic Factors) 1 
• All of the major immunologic elements play 
fundamental roles in initiating, propagating, and 
maintaining the autoimmune process of RA.  
• The exact orchestration of the cellular and cytokine 
events that lead to pathologic consequences (e.g., 
synovial proliferation and subsequent joint 
destruction) is complex, involving T and B cells, 
antigen-presenting cells (e.g., B cells, macrophages, 
and dendritic cells), and various cytokines.   
http://emedicine.medscape.com/article/331715-overview#a4 
Risk Factors and Etiology 
(Accent on Immunologic Factors) 2 
• Aberrant production and regulation of both 
proinflammatory and anti-inflammatory cytokines 
and cytokine pathways are found in RA.  
• The major difference between RA and other forms 
of inflammatory arthritis, such as psoriatic arthritis, 
lies not in their respective cytokine patterns but, 
rather, in the highly destructive potential of the RA 
synovial membrane and in the local and systemic 
autoimmunity.  
http://emedicine.medscape.com/article/331715-overview#a4 
US MLE TEST 
A 52-year-old female with a past medical history of 
rheumatoid arthritis presents to her primary care physician 
for complaints of increased swelling in her legs. She also 
notes her urine to be more "frothy" than usual. On physical 
exam she is noted to have a blood pressure of 142/90 mmHg. 
At all prior visits, this patient has had normal blood pressure. 
A 24-hour urine collection for protein contains 3.8 g. Which of 
the following is most likely present in this patient's kidney?   
1.  Immune complex deposits, 2.  Amyloid deposition, 
3.  Thickening of the glomerular basement membrane, 
4.  Bacterial infection, 5.  Normal findings on light 
microscopy.  https://www.mommd.com/usmle1to10.shtml 
US MLE TEST EXPLANATION 
The correct answer is 2.  The patient in this vignette most likely has 
secondary nephrotic syndrome as a result of AA amyloid deposition. 
Amyloidosis is the most probable cause of nephrotic syndrome in 
patients with rheumatoid arthritis (RA).  
Incorrect Answers: 
1: Immune complex deposits can be seen with acute post-steptococcal 
glomerulonephritis, among other conditions, and would not be seen 
with rheumatoid arthritis, 3: Thickening of the glomerular basement 
membrane is seen as the first consequence of diabetic kidney disease, 
4: This patient has no signs of an upper urinary tract infection, 5: Normal 
findings on light microscopy is consistent with minimal change disease, 
not rheumatoid arthritis-associated nephrotic syndrome. 
https://www.mommd.com/usmle1to10.shtml 
Mechanisms 1   
http://emedicine.medscape.com/article/331715-overview#a3 
• Mechanisms of RA are not completely understood.  
• An external trigger (e.g., cigarette smoking, 
infection, or trauma) that triggers an autoimmune 
reaction, leading to synovial hypertrophy and 
chronic joint inflammation along with the potential 
for extra-articular manifestations, is theorized to 
occur in genetically susceptible individuals. 
Mechanisms 2   
http://emedicine.medscape.com/article/331715-overview#a3 
• Synovial cell hyperplasia and endothelial cell 
activation are early events in the pathologic process 
that progresses to uncontrolled inflammation and 
consequent cartilage and bone destruction.   
• Inflammation and exuberant proliferation of the 
synovium (i.e., pannus) leads to destruction of 
various tissues, including cartilage (see the image 
below), bone, tendons, ligaments, and blood 
vessels.  
• Although the articular structures are the primary 
sites involved by RA, other tissues are also affected. 
Mechanisms   
(The Development of Rheumatoid Arthritis)  
https://www.hss.edu/conditions_an-in-depth-topic-review-of-rheumatoid-arthritis.asp 
Mechanisms   
(Joint Degradation)  
http://www.mayoclinic.org/diseases-conditions/rheumatoid-arthritis/home/ovc-20197388 http://www.jointxl.co.za/index.php/2-uncategorised/11-joint-degeneration-process 
Classification 
(International Classification of Diseases (ICD)) 1 
icd10coded.com/cm/ch9/I20-I25/ 
Arthropathies (M00-M25) 
Inflammatory polyarthropathies (M05-M14) 
 M05 Seropositive rheumatoid arthritis: M05.0 
Felty syndrome (Rheumatoid arthritis with 
splenoadenomegaly and leukopenia; M05.1 
†Rheumatoid lung disease (J99.0); M05.2 Rheumatoid 
vasculitis; M05.3† Rheumatoid arthritis with 
involvement of other organs and systems 
(rheumatoid: carditis (I52.8), endocarditis (I39.), 
myocarditis (141.8), myopathy (G73.7), pericarditis 
(I32.8), polyneuropathy (G63.6 );  
Classification 
(International Classification of Diseases (ICD)) 2 
icd10coded.com/cm/ch9/I20-I25/ 
M05.8 Other seropositive rheumatoid arthritis; M05.9 
Seropositive rheumatoid arthritis, unspecified 
 M06 Other rheumatoid arthritis: M06.0 
Seronegative rheumatoid arthritis; M06.1 Adult-onset 
Still disease; M06.2 Rheumatoid bursitis; M06.3 
Rheumatoid nodule; M06.4 Inflammatory 
polyarthropathy; M06.8 Other specified rheumatoid 
arthritis; M06.9 Rheumatoid arthritis, unspecified 
Clinical Investigation  
(Signs and Symptoms: Joints) 1 
• RA typically manifests with signs of inflammation, 
with the affected joints being swollen, warm, 
painful and stiff.  
• Most commonly involved are the small joints of the 
hands, feet and cervical spine, but larger joints like 
the shoulder and knee can also be involved. 
• The joints are often affected in a fairly symmetrical 
fashion, although the initial presentation may be 
asymmetrical.  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Joints) 2 
• Increased stiffness early in the morning is often a 
prominent feature of the RA and typically lasts for 
more than an hour; gentle movements may relieve 
symptoms in early stages of the disease.  
• As the pathology progresses the inflammatory 
activity leads to tendon tethering and erosion and 
destruction of the joint surface, which impairs 
range of movement and leads to deformity.   
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Joints) 3 
• Specific deformities include ulnar 
deviation, boutonniere deformity, swan neck 
deformity, and "Z-thumb" or "Z-deformity“, that 
consists of hyperextension of the interphalangeal 
joint, fixed flexion and subluxation of 
the metacarpophalangeal join (arthritis mutilans).  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Ulnar Deviation) 
http://america.pink/ulnar-deviation_4582071.html 
Ulnar deviation, also known as ulnar drift, is a hand 
deformity in which the swelling of the 
metacarpophalangeal joints causes the fingers to 
become displaced, tending towards the little finger. 
Its name comes from the displacement toward the 
ulna. 
Clinical Investigation  
(Boutonniere Deformity) 
http://www.hand-surgery.eu/en/hand-conditions/boutonniere-deformity 
Boutonnière deformity is a deformation of the finger 
in which the distal interphalangeal joint (DIP joint) is 
hyperextended, or bent away from the palm, while 
the proximal interphalangeal joint (PIP joint) is 
hyperflexed, or bent towards the palm. This results in 
a deformed finger. 
Clinical Investigation  
(Swan Neck Deformity) 
http://www.hand-surgery.eu/en/hand-conditions/boutonniere-deformity 
The shape of the finger looks like a Swan's neck. 
Splints can be used to help control the deformity if it 
is flexible. If deformity is present for a long enough 
time the joints may be destroyed and the deformity 
may become "fixed". 
Clinical Investigation  
(Z-Thumb) 
http://medicineinforme.blogspot.com/2015/10/rheumatoid-arthritis-new-medicine-for.html 
"Z-thumb" or "Z-deformity" consists of 
hyperextension of the interphalangeal joint, fixed 
flexion and subluxation of the metacarpophalangeal 
joint and gives a "Z" appearance to the thumb.  
Clinical Investigation  
(Signs and Symptoms: Skin) 1 
• The rheumatoid nodule (necrotizing granuloma) is 
the most common non joint feature and occur in 
30% of people. 
• The nodule has a central area of fibrinoid 
necrosis that may be fissured and which 
corresponds to the fibrin-rich necrotic material 
found in.   
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Skin) 2 
• The typical rheumatoid nodule may be a few mm to 
a few cm in diameter and is found over bony 
prominences, or other areas that repeated 
mechanical stress.  
• Nodules are associated with a positive RF titer and 
severe erosive arthritis; rarely, these can occur in 
internal organs or at diverse sites on the body. 
• Several forms of vasculitis occur in RA.   
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Skin) 3 
• More severe forms include livedo reticularis, which 
is a network of erythematous to purplish 
discoloration of the skin caused by the presence of 
an obliterative cutaneous capillaropathy. 
• Other, rather rare, skin associated symptoms 
include pyoderma gangrenosum, Sweet's syndrome, 
drug reactions, erythema nodosum, lobe 
panniculitis, atrophy of finger skin, palmar 
erythema, diffuse thinning (rice paper skin), and 
skin fragility (often worsened by corticosteroid use). 
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(The Rheumatoid Nodule) 
http://www.webmd.com/rheumatoid-arthritis/ss/slideshow-ra-overview 
Rheumatoid nodules are firm lumps under the skin. 
They form close to joints affected by rheumatoid 
arthritis. These bumps can be as large as a walnut or 
as small as a pea. Not everyone with RA gets them. 
Clinical Investigation  
(Livedo Reticularis) 
https://s-media-cache-ak0.pinimg.com/564x/10/52/88/105288f9361af0f564e62033336ebb31.jpg 
Livedo reticularis is a purplish-colored lace pattern under the skin. There is 
no raised or itchy rash on the surface of the skin, but the light and dark 
areas resemble a net-like pattern.  
Clinical Investigation  
(Signs and Symptoms: Lungs,Kidneys,Cardiovascular) 1 
• Fibrosis of the lungs and pleural effusions  are a 
recognized response to RA, and consequence of its 
therapy (e.g.,  methotrexate and leflunomide).   
• Renal amyloidosis can occur as a consequence of 
chronic inflammation, but RA may affect the 
kidney glomerulus directly through 
a vasculopathy or a mesangial infiltrate .  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Lungs,Kidneys,Cardiovascular) 2 
• , and risk of myocardial infarction  and stroke is 
markedly increased: other possible complications 
that may arise include: pericarditis, endocarditis, 
left ventricular failure, valvulitis and fibrosis.  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Other) 1 
• The eye can be affected in the form 
of episcleritis,  scleritis, or keratoconjunctivitis 
sicca, which can lead to keratitis and loss of vision.  
• Liver problems may be due to the underlying 
disease process or as a result of the medications 
used to treat the disease.  
• Anemia is by far the most common abnormality of 
the blood cells which can be caused by a variety of 
mechanisms.   
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Other) 2 
• A low white blood cell count usually only occurs in 
people with Felty's syndrome with an enlarged liver 
and spleen.  
• An increased platelet count occurs when 
inflammation is uncontrolled.  
• Peripheral neuropathy and mononeuritis 
multiplex may occur.  
• The most common problem is carpal tunnel 
syndrome caused by compression of the median 
nerve by swelling around the wrist.   
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Clinical Investigation  
(Signs and Symptoms: Other) 3 
• Atlanto-axial subluxation can occur, owing to 
erosion of the odontoid process and/or transverse 
ligaments in the cervical spine's connection to the 
skull.  
• Constitutional symptoms include fatigue, low 
grade fever, malaise, etc.  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
US MLE TEST 
A 29-year-old male presents to his primary care physician with 
complaints of pain with urination, eye dryness, and left ankle and 
knee pain that has developed over the last several weeks. He 
reports an illness 3 weeks ago that involved frequent diarrhea as 
well as nausea and vomiting. This episode resolved without 
treatment within 2 days. Physical exam shows moderate 
conjunctivitis; the knee and ankle joints show mild crepitus but no 
overlying redness or warmth. Which of the following is the best 
next step in the management of this patient?  
1.  Prescribe azithromycin and doxycycline, 2.  Initiate ibuprofen, 
3.  Aspiration of the left knee and ankle joints, 4.  Initiate PO 
prednisone, 5.  Obtain MRI of the left knee and ankle.  
 https://www.mommd.com/usmle1to10.shtml 
US MLE TEST EXPLANATION 
The correct answer is 2.  This patient's presentation is consistent with 
Reiter's syndrome, also known as reactive arthritis. Nonsteroidal anti-
inflammatory medications, such as ibuprofen, are the recommended 
first-line treatment to reduce the pain and inflammation associated with 
this disease.  
Incorrect Answers: 
1: Azithromycin and doxycycline would be the correct treatment had the 
patient suffered from a chlamydial infection that precipitated the 
reactive arthritis; however, he reports a preceding enteral infection, 3: 
Aspiration of the joints would be warranted if septic arthritis were 
suspected; however, there are no clues in the question stem to suggest 
a diagnosis of septic arthritis, 4: Systemic steroids are indicated for 
extremely severe or recalcitrant cases of reactive arthritis, 5: MRI is not 
an appropriate first imaging study.   
https://www.mommd.com/usmle1to10.shtml 
Diagnosis 
(Imaging) 1 
  • X-rays of the hands and feet are generally 
performed in people with a many joints affected: in 
RA, there may be no changes in the early stages of 
the disease, or the x-ray may demonstrate juxta-
articular osteopenia, soft tissue swelling and loss of 
joint space; as the disease advances, there may be 
bony erosions and subluxation. X-rays of other 
joints may be taken if symptoms of pain or swelling 
occur in those joints.  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Diagnosis 
(Imaging) 2 
  • Other medical imaging techniques such as magnetic 
resonance imaging (MRI) and ultrasound are also 
used in RA: 
• High-frequency transducers (10 MHz or higher) 
have improved the spatial resolution of 
ultrasound images; these images can depict 20% 
more erosions than conventional radiography, 
• Color Doppler and power Doppler ultrasound, 
which show vascular signals of active synovitis 
depending on the degree of inflammation, are 
useful in assessing synovial inflammation.   
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Diagnosis 
(Imaging: X-rays - Hands)  
Extensive fusion (ankylosis) at both wrists – all of the 
carpal bones have fused. The patient has had previous 
joint replacements at the right 2nd, 3rd and 4th MCP 
joints, while on the left you can see erosions at the 
MCP joints, with ulnar subluxation. 
http://www.svuhradiology.ie/case-study/rheumatoid-arthritis-hands/ 
Diagnosis 
(Imaging: X-rays – Elbow)  
This patient’s elbow has been severely eroded by RA – 
the olecranon now looks almost like a spoon, the 
radial head has disappeared, and the joint has 
become subluxed (partially dislocated) as a result. 
http://www.svuhradiology.ie/case-study/rheumatoid-arthritis-hands/ 
Diagnosis 
(Imaging: X-rays – Extraskeletal Manifestations in RA)  
A 45 year old female was diagnosed with seropositive 
rheumatoid arthritis, and lung involvement. X-rays 
showed right pleural effusion and in upper-middle 
side of right lung there was 1.6 centimetres mass 
looked like rheumatoid nodule. 
http://www.intechopen.com/books/innovative-rheumatology/extraskeletal-manifestations-in-rheumatoid-arthritis-clinical-cases 
Diagnosis 
(Imaging: MRI – Wrist )  
a) Areas of inflamed synovium are 
identified as hypointense signal 
(arrows);  
b) Inflamed synovium is identified as 
hyperintense regions (arrows) and 
bone marrow edema (asterisks); 
http://www.intechopen.com/books/innovative-rheumatology/extraskeletal-manifestations-in-rheumatoid-arthritis-clinical-cases 
C-d) Enhancement of both thickened synovium 
(arrows) and enhancing, reactive bone marrow 
edema (asterisks).  
Abbreviations: C, capitate; H, hamate; P, first 
metacarpal; R, radius. 
 
Diagnosis 
(Imaging: Power Doppler Ultrasound) 1  
a) Very early arthritis: the power 
Doppler signal is distributed at 
the levels of both the fat pad 
(arrowheads) and feeding vessel 
(arrows). 
b) Established disease: the power 
Doppler signal is located at areas 
of synovial proliferation that are 
very close to the bony cortex and 
metacarpal head hyaline 
cartilage (*).   
http://www.nature.com/nrrheum/journal/v9/n4/fig_tab/nrrheum.2013.39_F1.html 
Diagnosis 
(Imaging: Power Doppler Ultrasound) 2 
a) Long-standing disease: the 
power Doppler signal is 
located within the bone 
erosion (arrow).  
Abbreviations: M, metacarpal 
bone; P, proximal phalanx; T, 
finger extensor tendon. 
http://www.nature.com/nrrheum/journal/v9/n4/fig_tab/nrrheum.2013.39_F1.html 
c 
Diagnosis 
(Blood Tests) 1  
• When RA is clinically suspected, testing for the 
presence of RF and anti–citrullinated protein 
antibody (ACPAs) may be required. A negative RF 
does not rule out RA; rather, the arthritis is 
called seronegative. RF is also seen in other 
illnesses, for example Sjögren's syndrome, hepatitis 
C, systemic lupus erythematosus, chronic infections 
and etc.  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Diagnosis 
(Blood Tests) 2  
• The most common tests for ACPAs are the anti-CCP 
(cyclic citrullinated peptide) test, the Anti-
MCV assay (antibodies against mutated citrullinated 
Vimentin), a serological point-of-care test (POCT). 
This assay combines the detection of rheumatoid 
factor and anti-MCV for diagnosis of RA and shows 
a sensitivity of 72% and specificity of 99.7%.  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Diagnosis 
(Blood Tests) 3  
• Other blood tests are usually follows: 
the erythrocyte sedimentation rate (ESR),C-reactive 
protein, full blood count, kidney function, liver 
enzymes and other immunological tests 
(e.g., antinuclear antibody). Elevated ferritin levels 
can reveal hemochromatosis, a mimic of RA, or be a 
sign of Still's disease, a seronegative, usually 
juvenile, variant of rheumatoid arthritis. 
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 1) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
Score 
Target population (who should be tested?): patients who 
 1) have at least one joint with definite clinical synovitis (swelling)* 
 2) with the synovitis not better explained by another disease† 
Classification criteria for RA (score-based algorithm: add score of categories A–D a score of ≥6/10 is needed for 
classification of a patient as having definite RA)‡ 
 A. Joint involvement§ 
  1 large joint¶ 0 
  2−10 large joints 1 
  1−3 small joints (with or without involvement of large joints)** 2 
  4−10 small joints (with or without involvement of large joints) 3 
  >10 joints (at least one small joint)†† 5 
 B. Serology (at least 1 test result is needed for classification)‡‡ 
  Negative RF and negative ACPA 0 
  Low-positive RF or low-positive ACPA 2 
  High-positive RF or high-positive ACPA 3 
 C. Acute-phase reactants (at least one test result is needed for classification)§§ 
  Normal CRP and normal ESR 0 0 
  Abnormal CRP or normal ESR 1 1 
 D. Duration of symptoms¶¶ 
  <6 weeks 0 
  ≥6 weeks 1 
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 2) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• * The criteria are aimed at classification of newly 
presenting patients. In addition, patients with 
erosive disease typical of rheumatoid arthritis (RA) 
with a history compatible with prior fulfilment of 
the 2010 criteria should be classified as having RA. 
Patients with long-standing disease, including those 
whose disease is inactive (with or without 
treatment) who, based on retrospectively available 
data, have previously fulfilled the 2010 criteria 
should be classified as having RA.  
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 3) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• † Differential diagnoses differ in patients with 
different presentations, but may include conditions 
such as systemic lupus erythematosus, psoriatic 
arthritis and gout. If it is unclear about the relevant 
differential diagnoses to consider, an expert 
rheumatologist should be consulted. 
• ‡ Although patients with a score of less than 6/10 
are not classifiable as having RA, their status can be 
reassessed and the criteria might be fulfilled 
cumulatively over time.  
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 4) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• § Joint involvement refers to any swollen or tender 
joint on examination, which may be confirmed by 
imaging evidence of synovitis. Distal 
interphalangeal joints, first carpometacarpal joints 
and first metatarsophalangeal joints are excluded 
from assessment. Categories of joint distribution 
are classified according to the location and number 
of involved joints, with placement into the highest 
category possible based on the pattern of joint 
involvement.  
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 5) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• ¶ 'Large joints' refers to shoulders, elbows, hips, 
knees and ankles. 
• ** 'Small joints' refers to the metacarpophalangeal 
joints, proximal interphalangeal joints, second to 
fifth metatarsophalangeal joints, thumb 
interphalangeal joints and wrists.  
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 6) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• †† In this category, at least one of the involved 
joints must be a small joint; the other joints can 
include any combination of large and additional 
small joints, as well as other joints not specifically 
listed elsewhere.  
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 7) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• ‡‡ Negative refers to international unit (IU) values 
that are less than or equal to the upper limit of 
normal (ULN) for the laboratory and assay; low-
positive refers to IU values that are higher than the 
ULN but three of less times the ULN for the 
laboratory and assay; high-positive refers to IU 
values that are more than three times the ULN for 
the laboratory and assay. When rheumatoid factor 
(RF) information is only available as positive or 
negative, a positive result should be scored as low-
positive for RF.  
Diagnosis 
(2010 Rheumatoid Arthritis Classification: 8) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• §§ Normal/abnormal is determined by local 
laboratory standards. 
• ¶¶ Duration of symptoms refers to patient self-
report of the duration of signs or symptoms of 
synovitis (e.g., pain, swelling, tenderness) of joints 
that are clinically involved at the time of 
assessment, regardless of treatment status. 
ACPA, anti-citrullinated protein antibody; CRP, C-
reactive protein; ESR, erythrocyte sedimentation rate. 
Diagnosis 
(Tree Algorithm for classifying Definite RA) 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
Diagnosis 
(Monitoring Progression) 1 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• Lyme disease.  
• Reactive 
arthritis (previously 
Reiter's disease).  
• Crystal induced arthritis 
(gout, and pseudogout).  
• Osteoarthritis.  
• Systemic lupus 
erythematosus (SLE). 
•  Psoriatic arthritis.  
Diagnosis 
(Monitoring Progression) 1 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• Hemochromatosis. 
• Acute rheumatic 
fever. 
• Bacterial arthritis.  
• Gonococcal arthritis. 
• Ankylosing spondylitis.  
• Hepatitis C. 
• Sarcoidosis, amyloidosis, 
and Whipple's disease. 
Diagnosis 
(Clinical Disease Activity Index (CDAI)) 1 
http://www.rheumtutor.com/clinical-disease-activity-index-cdai/ 
• CDAI = SJC(28) + TJC(28) + PGA + EGA 
• SJC(28): Swollen 28-Joint Count (shoulders, 
elbows, wrists, MCPs, PIPs, knees) 
• TJC(28): Tender 28-Joint Count (shoulders, elbows, 
wrists, MCPs, PIPs, knees) 
• PGA: Patient Global disease Activity (patient’s self 
assessment of overall RA disease activity on a 
scale 1-10 where 10 is maximal activity)  
Diagnosis 
(Clinical Disease Activity Index (CDAI)) 2 
http://www.rheumtutor.com/clinical-disease-activity-index-cdai/ 
• EGA: Evaluator’s Global disease Activity 
(evaluator’s assessment of overall RA disease 
activity on a scale 1-10 where 10 is maximal 
activity) 
• Interpretation 
• Remission                               CDAI ≤ 2.8 
• Low Disease Activity             CDAI > 2.8 and ≤ 10 
• Moderate Disease Activity    CDAI > 10 and ≤ 22 
• High Disease Activity            CDAI > 22  
Diagnosis 
(Clinical Disease Activity Index (CDAI)) 3 
http://www.rheumtutor.com/clinical-disease-activity-index-cdai/ 
• A CDAI reduction of 6.5 represents moderate 
improvement. 
• Deficiencies 
• Does not include the ankles / feet 
• Does not include inflammatory markers (although 
this is what makes it a quick and 
useful clinical tool) 
Diagnosis 
(Disease Activity Score Calculator for RA) 
http://www.4s-dawn.com/DAS28/DAS28.html 
Diagnosis 
(Differential) 1 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• Lyme disease.  
• Reactive 
arthritis (previously 
Reiter's disease).  
• Crystal induced arthritis 
(gout, and pseudogout).  
• Osteoarthritis.  
• Systemic lupus 
erythematosus (SLE). 
•  Psoriatic arthritis.  
Diagnosis 
(Differential) 2 
http://www.rheumatology.org/Portals/0/Files/2010%20Rheumatoid%20Arthritis%20Classification_EXCERPT%202010.pdf 
• Hemochromatosis. 
• Acute rheumatic 
fever. 
• Bacterial arthritis.  
• Gonococcal arthritis. 
• Ankylosing spondylitis.  
• Hepatitis C. 
• Sarcoidosis, amyloidosis, 
and Whipple's disease. 
Treatment 
(General Principles) 1 
• There is no cure for RA, but treatments can improve 
symptoms and slow its progress.  
• • Treatment of patients with RA should aim for the 
best care and must be based on a shared decision 
between the patient and the rheumatologist. 
• • Rheumatologists are the specialists who should 
primarily care for patients with RA.  
http://www.medscape.com/viewarticle/821404 https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Treatment 
(General Principles) 2 
• • RA incurs high individual, societal, and medical 
costs, all of which should be considered in its 
management by the treating rheumatologist. 
• Disease-modifying treatment has the best results 
when it is started early and aggressively. 
http://www.medscape.com/viewarticle/821404 https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Treatment 
(Lifestyle modification) 1 
• Behavioral modification is a primary consideration 
in any RA management program. 
• Regular exercise is recommended as both safe and 
useful to maintain muscles strength and overall 
physical function. 
• Specific dietary measures have an effect.  
http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf 
Treatment 
(Lifestyle modification) 2 
• Occupational therapy has a positive role to play in 
improving functional ability of patients with RA. 
• Home visits and regular monitoring reduce the 
need for hospitalization and improve life 
expectancy. 
http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf 
Treatment 
(Patient Education) 1 
• Patient education and counseling help to reduce 
pain, disability, and frequency of physician visits.  
• The goal is to satisfy the patient’s informational 
needs regarding the diagnosis, prognosis, and 
treatment in appropriate detail.  
• To understand the patient’s perspective, requests, 
and fears, the physician must employ careful 
questioning and empathic listening.  
 
http://emedicine.medscape.com/article/331715-overview#a7 
Treatment 
(Patient Education) 2 
• The patient needs to know that the primary 
physician understands the situation and is available 
for support, advice, and therapy as the need arises.  
• Encouraging the patient to ask questions helps to 
communicate interest and caring. 
• Patient education may represent the most cost-
effective intervention for RA. 
 
http://emedicine.medscape.com/article/331715-overview#a7 
Treatment 
(Start Disease-Modifying Antirheumatic Drugs 
(DMARDs) as soon as possible (ASAP)) 
• Start DMARDs as soon as an RA diagnosis is made. 
• RA should always be treated with true 
antirheumatic therapies (DMARDs), both to provide 
the patient symptomatic relief and to prevent long-
term damage. 
• Some patients with very mild disease or with 
multiple contraindications might not be suitable for 
DMARD therapy.  
http://www.medscape.com/viewarticle/821404_2 
Treatment 
(Target Remission or Low Disease Activity) 1 
• Treatment should focus on reaching remission or 
low disease activity.  
• Improvement in physical functioning and slowing or 
stopping of structural damage are implicit in the 
definition of "remission." 
• For patients in whom remission cannot be achieved, 
low disease activity defined by a composite 
measure is a reasonable treatment goal.  
http://www.medscape.com/viewarticle/821404_2 
Treatment 
(Target Remission or Low Disease Activity) 2 
• Clinicians need to train themselves to think in terms 
of the disease state that the patient has to achieve, 
and simply achieving any improvement, or having a 
good feeling about the treatment result, is no 
longer acceptable. 
http://www.medscape.com/viewarticle/821404_2 
Treatment 
(Target Remission or Low Disease Activity) 1 
• Monitor active disease every 1-3 months. 
• If there is no improvement by 3 months from the 
start of treatment or the target is not reached by 6 
months, treatment should be modified. 
• Monitoring should be performed as frequently as a 
patient's disease requires.  
http://www.medscape.com/viewarticle/821404_2 
Treatment 
(Target Remission or Low Disease Activity) 2 
• Maximizing treatment efficacy includes reaching an 
optimal methotrexate (MTX) dose within "a few 
weeks" and maintaining the maximal dose (25-30 
mg/week) for at least 8 weeks. 
• Maximal efficacy with most treatments may take up 
to 6 months to achieve in some patients. 
http://www.medscape.com/viewarticle/821404_2 
Treatment 
(Disease modifying agents: 1) 
• DMARDs are a diverse collection of drugs that 
improve symptoms, decrease joint damage, and 
improve overall functional abilities. 
• DMARDs should be started early as they result in 
RA remission in approximately half of people and 
improved outcomes overall.  
http://www.medscape.com/viewarticle/821404 
Treatment 
(Disease modifying agents: 2) 
• The following drugs are considered as DMARDs: 
methotrexate, hydroxychloroquine, sulfasalazine, 
leflunomide, monoclonal antibodies (certolizumab, 
rituximab, tocilizumab, infliximab and 
etanercept),  injectible man-made protein used for 
treating rheumatoid arthritis abatacept, and 
interleukin 1 anakinra.   
http://www.medscape.com/viewarticle/821404 
Treatment 
(Disease modifying agents: 3) 
• The most commonly used agent is methotrexate 
with other frequently used agents including 
sulfasalazine and leflunomide.  
• Sodium aurothiomalate (Gold) and cyclosporin are 
less commonly used due to more common adverse 
effects.   
http://www.medscape.com/viewarticle/821404 
Treatment 
(Disease modifying agents: 4) 
• Methotrexate is the most important and useful 
DMARD and is usually the first treatment. Adverse 
effects should be monitored regularly with toxicity 
including gastrointestinal, hematologic, pulmonary, 
and hepatic. Side effects such as nausea, vomiting 
or abdominal pain can be reduced by taking folic 
acid. The most common undesirable effect is that it 
increases liver enzymes in almost 15% of people  
http://www.medscape.com/viewarticle/821404 
Treatment 
(Disease modifying agents: 5) 
• Biological agents should generally only be used if 
methotrexate and other conventional agents are 
not effective after a trial of three months. They are 
associated with a higher rate of serious infections as 
compared to other DMARDs. They are often used in 
combination with either methotrexate or 
leflunomide.    
http://www.medscape.com/viewarticle/821404 
Treatment 
(Anti-inflammatory agents) 1 
• NSAIDs reduce both pain and stiffness in those with 
RA. Generally they appear to have no effect on 
people's long term disease course and thus are no 
longer first line agents. NSAIDs should be used with 
caution in those 
with gastrointestinal, cardiovascular, or kidney 
problems. 
• Use of methotrexate together with NSAIDS is safe, if 
adequate monitoring is done.  
http://www.medscape.com/viewarticle/821404 
Treatment 
(Anti-inflammatory agents) 2 
• Glucocorticoids can be used in the short term for 
flare-ups, while waiting for slow-onset drugs to take 
effect. Injection of glucocorticoids into individual 
joints is also effective. While long-term use reduces 
joint damage it also results in osteoporosis and 
susceptibility to infections, and thus is not 
recommended. 
http://www.medscape.com/viewarticle/821404 
Treatment 
(Disease-Modifying Antirheumatic Drugs) 
Nonbiologic DMARDS 
• Hydroxychloroquine 
• Azathioprine 
• Sulfasalazine 
• Methotrexate 
• Leflunomide 
• Cyclosporine 
• Gold salts 
• D-penicillamine 
• Minocycline 
Biologic  DMARDS 
TNF-inhibiting 
• Etanercept 
• Infliximab 
• Adalimumab 
• Certolizumab 
• Golimumab 
non-TNF-inhibiting 
• Rituximab 
• Anakinra 
• Abatacept 
• Tocilizumab 
• Tofacitinib 
 
http://emedicine.medscape.com/article/331715-overview#a1 
Treatment 
(Risk Genes and Approved RA Drugs) 
http://www.nature.com/nrrheum/journal/v11/n6/full/nrrheum.2015.7.html?message-global=remove 
Treatment 
(Surgery) 1 
• In early phases of the disease, an arthroscopic or 
open synovectomy may be performed. It consists of 
the removal of the inflamed synovia and prevents a 
quick destruction of the affected joints.  
• Other surgical treatments 
include tenosynovectomy, tendon realignment, 
reconstructive surgery or arthroplasty, and 
arthrodesis.  
http://www.medscape.com/viewarticle/821404 
Treatment 
(Surgery) 2 
• Severely affected joints may require joint 
replacement surgery, such as knee replacement. 
• Postoperatively, physiotherapy is always necessary. 
http://www.medscape.com/viewarticle/821404 
Treatment 
(Nonpharmacologic, Nonsurgical therapies) 
• Heat and cold therapies. 
• Orthotics and splints. 
• Therapeutic exercise. 
• Occupational therapy. 
• Adaptive equipment. 
• Joint-protection education. 
• Energy-conservation education. 
http://mymedsupply.com/wp-content/uploads/2015/03/Hot-and-Cold-Therapy-Shoulder.jpg http://emedicine.medscape.com/article/331715-overview#a1 
Treatment 
(Home Care Services) 
• In spite of medical treatment, RA often progresses 
and causes the person to have more and more 
difficulty in conducting their usual activities of daily 
living such as bathing or dressing or difficulty with 
regular homemaking activities such as laundry or 
routine cleaning.  
• Busy families may find it to be challenging to keep 
up with theses needs.  
• These families can benefit from the assistance of a 
home care aide or homemaker. 
http://www.interimhealthcare.com/services/home-care/information/arthritis 
Prognosis  
• The clinical course of RA is generally one of 
exacerbations and remissions. 40% of patients 
become disabled after 10 years, but outcomes are 
highly variable. 
• Poor prognostic factors include persistent synovitis, 
early erosive disease, extra-articular findings, 
positive serum RF findings, positive serum anti-CCP 
autoantibodies, family history of RA, poor 
functional status, socioeconomic factors, elevated 
acute phase response, and increased clinical 
severity. 
http://emedicine.medscape.com/article/331715-overview#a6 en.wikipedia.org/wiki/Heart_failure#Prognosis 
Prophylaxis 1 
• There is no known prevention for the RA other than 
the reduction of risk factors. 
• People with RA have an increased risk of infections 
and mortality and recommended vaccinations can 
reduce these risks. 
• The killed influenza vaccine should be received 
annually.  
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Prophylaxis 2 
• The pneumococcal vaccine should be administered 
twice for people under the age 65 and once for 
those over 65. 
• The live-attenuated zoster vaccine should be 
administered once after the age 60, but is not 
recommended in people on a tumor necrosis factor 
alpha blocker. 
https://en.wikipedia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Abbreviations  
ASAP - as soon as possible 
ACPA - anti-citrullinated protein 
antibody 
ACR - American College of 
Rheumatology 
anti-CCP - cyclic citrullinated peptide 
Anti-MCV assay - antibodies against 
mutated citrullinated Vimentin 
CCP = cyclic citrullinated peptide 
CDAI - Clinical Disease Activity Index  
CRP - C-reactive protein 
DIP or DIJ – distal 
interphalangeal joints 
DMARDs - disease-modifying 
antirheumatic drugs  
EBV - Epstein-Barr virus 
 
 
ESR - erythrocyte sedimentation rate 
IP or IJ - interphalangeal joints 
IU - international unit   
MCPs - metacarpophalangeal joints  
MRI - magnetic resonance imaging 
MTX - methotrexate 
NSAIDs - nonsteroidal anti-inflammatory 
drugs SLE - systemic lupus erythematosus 
OC – oral contraceptives  
PIP or PIJ – proximal interphalangeal joints 
POCT - point-of-care test 
RA – rheumatoid arthritis 
RF - rheumatoid factor   
TNF - tumor necrosis factor 
ULN - upper limit of normal 
Diagnostic and treatment guidelines 
2015 American College of Rheumatology Guideline for the 
Treatment of Rheumatoid Arthritis 
Rheumatoid arthritis in adults: management 
Clinical guideline for the diagnosis and management of early 
rheumatoid arthritis 
New Rheumatoid Arthritis Management Guidelines: A Quick and 
Easy Guide 
Rheumatoid Arthritis 
Rheumatoid Arthritis 
 
